Résultats de la recherche
10
Tout
Aanastra Inc to Present Multiple Posters on RNA Therapeutics at the American Association for Cancer Research (AACR) Annual Meeting 2024
03 avr. 2024 06h30 HE
|
Aanastra Inc
Aanastra to present its RNA peptide therapeutics technology at AACR conference
Global Factor IX Drug Pipeline Landscape Report 2024: Therapeutic Assessment by Stage, Route of Administration, and Molecule Type
29 févr. 2024 10h52 HE
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Factor IX - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
Hemophilia Market Size, Share & Trends Analysis Report 2023-2030
21 août 2023 08h48 HE
|
Research and Markets
Dublin, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The "Hemophilia Market Size, Share & Trends Analysis Report By Type (Hemophilia A), By Treatment Type (On-demand), By Therapy (Gene Therapy &...
Global Hemophilia Market Report 2023: Increased Focus on Prophylactic Treatment Drives Growth
22 févr. 2023 04h28 HE
|
Research and Markets
Dublin, Feb. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Hemophilia Market (By Treatment Regimen, Type & Therapy): Insights & Forecast with Potential Impact of COVID-19 (2023-2027)" report has...
Worldwide Hemophilia Treatment Industry to 2030 - by Product, Hemophilia Type and Region
02 févr. 2023 12h43 HE
|
Research and Markets
Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Global Blood Plasma Derivatives Market Report 2022: Featuring Bayer, Takeda Pharmaceutical, Grifols, Biotest & More
02 déc. 2022 04h53 HE
|
Research and Markets
Dublin, Dec. 02, 2022 (GLOBE NEWSWIRE) -- The "Global Blood Plasma Derivatives Market Size, Share & Industry Trends Analysis Report by Application, End-user, Type (Immunoglobulin, Albumin,...
Global Hemophilia Treatment Market Report to 2031: Players Include Bayer, Pfizer, F. Hoffmann-La Roche and CSL
11 nov. 2022 04h50 HE
|
Research and Markets
Dublin, Nov. 11, 2022 (GLOBE NEWSWIRE) -- The "Hemophilia Treatment Market By Type, By Drug Therapy: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ...
Acquired Hemophilia Treatment Global Market Report 2022: Rise in Geriatric Population Remains as Key Growth Driver
31 août 2022 05h08 HE
|
Research and Markets
Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Acquired Hemophilia Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Insights on the Hemophilia Global Market to 2026 - Increased Focus on Prophylactic Treatment Presents Opportunities
03 mars 2022 04h38 HE
|
Research and Markets
Dublin, March 03, 2022 (GLOBE NEWSWIRE) -- The "Global Hemophilia Market: Size, Trends & Forecast with Impact of COVID-19 (2022-2026)" report has been added to ResearchAndMarkets.com's offering....
Global Hemophilia Market Key Trends & Developments 2022-2026: Shifting Focus to Extended Half Life Therapies and Development of Novel Hemophilia Treatments
24 févr. 2022 06h48 HE
|
Research and Markets
Dublin, Feb. 24, 2022 (GLOBE NEWSWIRE) -- The "Global Hemophilia Market (By Treatment Regimen, Type & Therapy): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)" report has...